Ingebjørg Buajordet

Summary

Affiliation: Statens legemiddelverk
Country: Norway

Publications

  1. ncbi Fatal adverse drug events: the paradox of drug treatment
    I Buajordet
    Pharmacovigilance Section, The Norwegian Medicines Agency, Oslo, Norway
    J Intern Med 250:327-41. 2001
  2. ncbi Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital
    I Buajordet
    Department of Paediatrics, Ullevaal University Hospital, Oslo, Norway
    Acta Paediatr 91:88-94. 2002
  3. ncbi Adverse events after naloxone treatment of episodes of suspected acute opioid overdose
    Ingebjørg Buajordet
    Clinical Pharmacology and Toxicology Unit, Clinical Chemistry Department, Ullevaal University Hospital, Oslo, Norway
    Eur J Emerg Med 11:19-23. 2004
  4. ncbi [Somadril recalled in Norway]
    Ingebjørg Buajordet
    Statens legemiddelverk, Sven Oftedals vei 8, 0950 Oslo
    Tidsskr Nor Laegeforen 127:1397. 2007
  5. ncbi [Can the screening of blood samples identify adverse drug reactions?]
    Ingebjørg Buajordet
    Statens legemiddelverk, Sven Oftedalsvei 8, 0950 Oslo
    Tidsskr Nor Laegeforen 127:1637-9. 2007

Detail Information

Publications5

  1. ncbi Fatal adverse drug events: the paradox of drug treatment
    I Buajordet
    Pharmacovigilance Section, The Norwegian Medicines Agency, Oslo, Norway
    J Intern Med 250:327-41. 2001
    ..Study patient characteristics, morbidity patterns and drug regimens associated with fatal adverse drug events (FADEs) amongst medical department inpatients...
  2. ncbi Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital
    I Buajordet
    Department of Paediatrics, Ullevaal University Hospital, Oslo, Norway
    Acta Paediatr 91:88-94. 2002
    ..The reporting of events by parents was a useful supplement to the screening of patient records...
  3. ncbi Adverse events after naloxone treatment of episodes of suspected acute opioid overdose
    Ingebjørg Buajordet
    Clinical Pharmacology and Toxicology Unit, Clinical Chemistry Department, Ullevaal University Hospital, Oslo, Norway
    Eur J Emerg Med 11:19-23. 2004
    ..The aim of this study was to determine the frequencies and characteristics of adverse events related to this out-of-hospital administration by paramedics...
  4. ncbi [Somadril recalled in Norway]
    Ingebjørg Buajordet
    Statens legemiddelverk, Sven Oftedals vei 8, 0950 Oslo
    Tidsskr Nor Laegeforen 127:1397. 2007
  5. ncbi [Can the screening of blood samples identify adverse drug reactions?]
    Ingebjørg Buajordet
    Statens legemiddelverk, Sven Oftedalsvei 8, 0950 Oslo
    Tidsskr Nor Laegeforen 127:1637-9. 2007
    ..Analysis of blood samples may identify adverse drug reactions (ADRs) and risk situations. The study objective was to validate a method for in-hospital detection of ADRs based on screening of blood samples...